Pharmaceutical companies maintained profits in the third quarter, helped by cost controls, but sales gains were modest.

Merck, the US drugmaker, posted earnings well above Wall Street’s forecasts yesterday, while numbers from Novartis, Bristol Myers Squibb and Schering Plough were in line with market expectations.